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Background
New daily persistent headache (NDPH) is a primary
headache disorder, characterized by chronic and unre-
mitting daily headache with abrupt onset and more than
three months in duration. It lacks typical clinical features,
the pain being suggestive of chronic migraine without
aura or tension-type headache. It may be self-limiting
within months or years without therapy, or be refractory
to most treatments.
Case report
M.L., female, 19 years old, first seen in August 2013, with
left renal hypoplasia and Raynaud’s phenomenon, referred
since December 24, 2012 (this date was specifically
remembered) the onset of a daily, continuous and unre-
mitting headache localized bilaterally in the forehead and
occipital region, with pressing/tightening features, tension
in both shoulder muscles and lack of general and local
autonomic symptoms. The intensity of pain was variable,
with paroxysms of disabling intensity. No history of famil-
ial headache. No psychiatric features were diagnosed. The
patient did not remember head or cervical traumas.
Neurological examination was unremarkable. EEG and
angio-RM, as well as CSF examination, were negative.
The pain was refractory to various symptomatic and
prophylactic drugs, including NSAIDs, acetaminophen,
dipyrone, rizatriptan, and amitryptiline, propranolol,
flunarizine, pizotifen, pregabalin, duloxetin and to
non-pharmacological therapy, such as, acupuncture and
positioning of bite-plane. A cycle of i.v. acyclovir was per-
formed without success.
She was treated with botulinum toxin type A 195 U s.c.
since January 2014, with cycles every three months.
The pain partly relieved after the first cycle and subsided
almost completely after the third cycle, becoming tolerable
although the patient never became headache free. She is
still regularly in treatment, and consistently experienced
relief of headache immediately after each cycle, with sub-
sequent worsening of pain, without side effects.
Discussion
The clinical characteristics of the headache, normality of
examinations and refractoriness to most therapies were
in accordance with NDPH. Other cases of responsive-
ness of this headache entity to botulinum toxin have
been described [1], but the therapy has still not been
approved in Italy for NDPH, due to the lack of con-
trolled studies. In this case we can reasonably exclude a
spontaneous remission of the headache because of the
persistence of less severe pain, clearly relieved by the
therapy. Botulinum toxin type A was the only effective
treatment in this case, and strongly contributed to the
improvement of the quality of life of the patient.
Conclusions
We present this case report as a stimulus to perform more
observations to test the validity of botulinum toxin in
chronic refractory primary headaches, including NDPH.
Written informed consent to publication was obtained
from the patient(s).
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